Patent application number | Description | Published |
20140096014 | METHOD FOR ENABLING DYNAMIC CLIENT USER INTERFACES ON MULTIPLE PLATFORMS FROM A COMMON SERVER APPLICATION VIA METADATA - A system and method for facilitating modifying a client user interface display screen via a server and accompanying server-side software. An example method includes employing a client device to receive metadata from a server, wherein the metadata includes a description of one or more User Interface (UI) elements to be displayed on the client device; and using an application running on the client device to employ the metadata to display one or more platform-specific user interface features based on a platform on which the application is running. In general, example embodiments described herein include software and accompanying methods for enabling generation of dynamic native client user interfaces on multiple different client platforms based on common metadata definitions (or code for generating the metadata definitions) delivered to the different client platforms. | 04-03-2014 |
20150088866 | ACCESSING APPLICATION SERVICES FROM FORMS - A method, system, and computer program product for computer-aided deployment of mobile system apps for accessing enterprise applications. A form field service request originates from a non-native system. The service request comprises at least one form field identifier. The native computer system processes the service request using the form field identifier to identify corresponding forms stored at locations accessible to the native system (e.g., in a database engine). The native computer system processes the service request to map the form field to business logic operations and/or to other actions before delivering the service request to a native application that is configured to process the form field using native business logic. The business logic within the native application produces results from the native application which in turn are sent from the native application to the non-native system. The non-native system comprises any number of mobile devices, smart phones, and/or tablet devices. | 03-26-2015 |
20150089469 | COMPUTER-AIDED DEVELOPMENT OF NATIVE MOBILE APPLICATION CODE - A method, system, and computer program product for computer-aided software application development. A synthesizer commences upon receiving a mobile device identifier and additional information such as an application identifier, an object model, and/or a form identifier, then analyzing the additional information to determine what form(s) to implement on the mobile device. Further synthesis processing includes analyzing the forms to determine a set of functions to implement on the identified mobile device. Using the determined set of functions, native application code modules are retrieved from a repository. The retrieved native application code modules correspond to the set of functions. The code modules are integrated together to generate a native mobile application, which can be deployed to a mobile device. Messages from the mobile device are intercepted so as to emulate form processing of a back-end application. Any back-end applications that use the form can be accessed by the native mobile application. | 03-26-2015 |
20150089470 | RULE-BASED AUTOMATIC CLASS GENERATION FROM A JSON MESSAGE - A method, system, and computer program product for Java development environments. The method commences upon receiving a set of one or more rules to be applied to one or more JSON messages, then generating of one or more Java classes respective to received JSON messages. The received JSON messages can be retrieved from a repository for JSON message files, or the JSON messages can be received by sniffing a message transmitted over a network link. The rules can be applied according to one or more precedence regimes, and applying the precedence regimes over the two or more rules can be considered in a pre-processing step performed before receiving a JSON message or can be considered after receiving a JSON message. | 03-26-2015 |
Patent application number | Description | Published |
20130230646 | METHOD AND APPARATUS FOR SOLID-STATE MICROBATTERY PHOTOLITHOGRAPHIC MANUFACTURE, SINGULATION AND PASSIVATION - A method for producing a thin film lithium battery is provided, comprising applying a cathode current collector, a cathode material, an anode current collector, and an electrolyte layer separating the cathode material from the anode current collector to a substrate, wherein at least one of the layers contains lithiated compounds that is patterned at least in part by a photolithography operation comprising removal of a photoresist material from the layer containing lithiated compounds by a process including a wet chemical treatment. Additionally, a method and apparatus for making lithium batteries by providing a first sheet that includes a substrate having a cathode material, an anode material, and a LiPON barrier/electrolyte layer separating the cathode material from the anode material; and removing a subset of first material to separate a plurality of cells from the first sheet. In some embodiments, the method further includes depositing second material on the sheet to cover the plurality of cells; and removing a subset of second material to separate a plurality of cells from the first sheet. | 09-05-2013 |
20150102530 | METHOD AND APPARATUS FOR SOLID-STATE MICROBATTERY PHOTOLITHOGRAPHIC MANUFACTURE, SINGULATION AND PASSIVATION - A method for producing a thin film lithium battery is provided, comprising applying a cathode current collector, a cathode material, an anode current collector, and an electrolyte layer separating the cathode material from the anode current collector to a substrate, wherein at least one of the layers contains lithiated compounds that is patterned at least in part by a photolithography operation comprising removal of a photoresist material from the layer containing lithiated compounds by a process including a wet chemical treatment. Additionally, a method and apparatus for making lithium batteries by providing a first sheet that includes a substrate having a cathode material, an anode material, and a LiPON barrier/electrolyte layer separating the cathode material from the anode material; and removing a subset of first material to separate a plurality of cells from the first sheet. In some embodiments, the method further includes depositing second material on the sheet to cover the plurality of cells; and removing a subset of second material to separate a plurality of cells from the first sheet. | 04-16-2015 |
Patent application number | Description | Published |
20090214899 | BATTERY LAYOUT INCORPORATING FULL METAL EDGE SEAL - A first current collector on the first surface of the substrate and a second current collector having a first surface and a perimeter. One of the first and second current collector is an anode current collector and the other is a cathode current collector. The battery also comprises a cathode material having a perimeter, the cathode material being located on the cathode current collector; an electrolyte layer having a perimeter, the electrolyte separating the cathode material from the anode current collector; an insulation layer having a perimeter, the insulation layer together with the electrolyte layer separating the anode current collector from the cathode material and the cathode current collector. A first passivation layer generally overlies at least the perimeter of the cathode material, the perimeter of the electrolyte, and the perimeter of the insulation layer, the first passivation layer being electrically coupled to the first current collector and forming a continuous metal to metal seal around a defined area of the first current collector. The first passivation layer has a via opening. A second passivation layer is electrically coupled to the second current collector through the via opening of the first passivation layer. | 08-27-2009 |
20150280284 | THIN FILM BATTERIES COMPRISING A GLASS OR CERAMIC SUBSTRATE - A thin film battery comprises a glass or ceramic substrate having a coefficient of thermal expansion (“CTE”) of from about 7 to about 10 ppm/° K, a continuous metal or metal oxide cathode current collector and having a thickness of less than about 3 micrometers, the cathode current collector being superjacent to the glass or ceramic substrate, a cathode material layer comprising lithium transition metal oxides that is a continuous film having a thickness of from about 10 to about 80 micrometers, the cathode material layer being superjacent to the cathode current collector, a LiPON electrolyte layer superjacent to the cathode material layer and having a thickness of from about 0.5 to about 4 micrometers, and an anode current collector with an optional anode material. Methods of making and using the batteries are described. | 10-01-2015 |
Patent application number | Description | Published |
20090275812 | Flowometry in Optical Coherence Tomography for Analyte Level Estimation - Optical coherence tomography (herein “OCT”) based analyte monitoring systems are disclosed. In one aspect, techniques are disclosed that can identify fluid flow in vivo (e.g., blood flow), which can act as a metric for gauging the extent of blood perfusion in tissue. For instance, if OCT is to be used to estimate the level of an analyte (e.g., glucose) in tissue, a measure of the extent of blood flow can potentially indicate the presence of an analyte correlating region, which would be suitable for analyte level estimation with OCT. Another aspect is related to systems and methods for scanning multiple regions. An optical beam is moved across the surface of the tissue in two distinct manners. The first can be a coarse scan, moving the beam to provide distinct scanning positions on the skin. The second can be a fine scan where the beam is applied for more detailed analysis. | 11-05-2009 |
20100113900 | Multispot Monitoring for Use in Optical Coherence Tomography - Optical coherence tomography (herein “OCT”) based analyte monitoring systems are disclosed. In one aspect, techniques are disclosed that can identify fluid flow in vivo (e.g., blood flow), which can act as a metric for gauging the extent of blood perfusion in tissue. For instance, if OCT is to be used to estimate the level of an analyte (e.g., glucose) in tissue, a measure of the extent of blood flow can potentially indicate the presence of an analyte correlating region, which would be suitable for analyte level estimation with OCT. Another aspect is related to systems and methods for scanning multiple regions. An optical beam is moved across the surface of the tissue in two distinct manners. The first can be a coarse scan, moving the beam to provide distinct scanning positions on the skin. The second can be a fine scan where the beam is applied for more detailed analysis. | 05-06-2010 |
20110015505 | METHOD FOR DATA REDUCTION AND CALIBRATION OF AN OCT-BASED PHYSIOLOGICAL MONITOR - The present invention relates to a method and system for estimating blood analyte levels using a noninvasive optical coherence tomography (OCT) based physiological monitor. An algorithm correlates OCT-based estimated blood analyte data with actual blood analyte data determined by other methods, such as invasively. OCT-based data is fit to the obtained blood analyte measurements to achieve the best correlation. Once the algorithm has generated sets of estimated blood analyte levels, it may refine the number of sets by applying one or more mathematical filters. The OCT-based physiological monitor can be calibrated using an Intensity Difference plot or the Pearson Product Moment Correlation method. | 01-20-2011 |
20110319731 | METHODS FOR NONINVASIVELY MEASURING ANALYTE LEVELS IN A SUBJECT - A method for noninvasively measuring analytes such as blood glucose levels includes using a non-imaging OCT-based system to scan a two-dimensional area of biological tissue and gather data continuously during the scanning. Structures within the tissue where measured-analyte-induced changes to the OCT data dominate over changes induced by other analytes are identified by focusing on highly localized regions of the data curve produced from the OCT scan which correspond to discontinuities in the OCT data curve. The data from these localized regions then can be related to measured analyte levels. | 12-29-2011 |
20120209094 | MONITORING BLOOD CONSTITUENT LEVELS IN BIOLOGICAL TISSUE - In accordance with the invention, a low coherence interferometer is used to non-invasively monitor the concentration of glucose in blood by shining a light over a surface area of human or animal tissue, continuously scanning the light over a two dimensional area of the surface, collecting the reflected light from within the tissue and constructively interfering this reflected light with light reflected along a reference path to scan the tissue in depth. Since the reflection spectrum is sensitive to glucose concentration at particular wavelengths, measurement and analysis of the reflected light provides a measure of the level of glucose in the blood. The measurement of glucose is taken from multiple depths within blood-profused tissue, and sensitivity is preferably enhanced by the use of multiple wavelengths. Noise or speckle associated with this technique is minimized by continuously scanning the illuminated tissue in area and depth. | 08-16-2012 |
20120277554 | APPARATUS AND METHOD FOR CREATING A STABLE OPTICAL INTERFACE - A system and a method for creating a stable and reproducible interface of an optical sensor system for measuring blood glucose levels in biological tissue include a dual wedge prism sensor attached to a disposable optic that comprises a focusing lens and an optical window. The disposable optic adheres to the skin to allow a patient to take multiple readings or scans at the same location. The disposable optic includes a Petzval surface placed flush against the skin to maintain the focal point of the optical beam on the surface of the skin. Additionally, the integrity of the sensor signal is maximized by varying the rotation rates of the dual wedge prisms over time in relation to the depth scan rate of the sensor. Optimally, a medium may be injected between the disposable and the skin to match the respective refractive indices and optimize the signal collection of the sensor. | 11-01-2012 |
20130060108 | METHOD FOR DATA REDUCTION AND CALIBRATION OF AN OCT-BASED PHYSIOLOGICAL MONITOR - The present invention relates to a method and system for estimating blood analyte levels using a noninvasive optical coherence tomography (OCT) based physiological monitor. An algorithm correlates OCT-based estimated blood analyte data with actual blood analyte data determined by other methods, such as invasively. OCT-based data is fit to the obtained blood analyte measurements to achieve the best correlation. Once the algorithm has generated sets of estimated blood analyte levels, it may refine the number of sets by applying one or more mathematical filters. The OCT-based physiological monitor can be calibrated using an Intensity Difference plot or the Pearson Product Moment Correlation method. | 03-07-2013 |
20140051952 | FLOWOMETRY IN OPTICAL COHERENCE TOMOGRAPHY FOR ANALYTE LEVEL ESTIMATION - Optical coherence tomography (herein “OCT”) based analyte monitoring systems are disclosed. In one aspect, techniques are disclosed that can identify fluid flow in vivo (e.g., blood flow), which can act as a metric for gauging the extent of blood perfusion in tissue. For instance, if OCT is to be used to estimate the level of an analyte (e.g., glucose) in tissue, a measure of the extent of blood flow can potentially indicate the presence of an analyte correlating region, which would be suitable for analyte level estimation with OCT. Another aspect is related to systems and methods for scanning multiple regions. An optical beam is moved across the surface of the tissue in two distinct manners. The first can be a coarse scan, moving the beam to provide distinct scanning positions on the skin. The second can be a fine scan where the beam is applied for more detailed analysis. | 02-20-2014 |
20140094667 | NONINVASIVELY MEASURING ANALYTE LEVELS IN A SUBJECT - A method for noninvasively measuring analyte levels includes using a non-imaging OCT-based system to scan a two-dimensional area of biological tissue and gather data continuously during the scanning. Structures within the tissue where measured-analyte-induced changes to the OCT data dominate over changes induced by other analytes are identified by focusing on highly localized regions of the data curve produced from the OCT scan which correspond to discontinuities in the OCT data curve. The data from these localized regions then can be related to measured analyte levels. | 04-03-2014 |
20140336481 | MULTISPOT MONITORING FOR USE IN OPTICAL COHERENCE TOMOGRAPHY - Optical coherence tomography (herein “OCT”) based analyte monitoring systems are disclosed. In one aspect, techniques are disclosed that can identify fluid flow in vivo (e.g., blood flow), which can act as a metric for gauging the extent of blood perfusion in tissue. For instance, if OCT is to be used to estimate the level of an analyte (e.g., glucose) in tissue, a measure of the extent of blood flow can potentially indicate the presence of an analyte correlating region, which would be suitable for analyte level estimation with OCT. Another aspect is related to systems and methods for scanning multiple regions. An optical beam is moved across the surface of the tissue in two distinct manners. The first can be a coarse scan, moving the beam to provide distinct scanning positions on the skin. The second can be a fine scan where the beam is applied for more detailed analysis. | 11-13-2014 |
20150126830 | APPARATUS AND METHOD FOR CREATING A STABLE OPTICAL INTERFACE - A system and a method for creating a stable and reproducible interface of an optical sensor system for measuring blood glucose levels in biological tissue include a dual wedge prism sensor attached to a disposable optic that comprises a focusing lens and an optical window. The disposable optic adheres to the skin to allow a patient to take multiple readings or scans at the same location. The disposable optic includes a Petzval surface placed flush against the skin to maintain the focal point of the optical beam on the surface of the skin. Additionally, the integrity of the sensor signal is maximized by varying the rotation rates of the dual wedge prisms over time in relation to the depth scan rate of the sensor. Optimally, a medium may be injected between the disposable and the skin to match the respective refractive indices and optimize the signal collection of the sensor. | 05-07-2015 |
Patent application number | Description | Published |
20080296975 | BACK-UP POWER SYSTEM - A substantially uninterruptible backup power system to provide power to common household appliances comprises a rechargeable battery, a trickle-charging circuit to keep the battery fully charged at all times from the receptacle power, a DC to AC inverter to supply standard AC line voltage from the battery to the lamp, a relay switch, controlled by main power voltage, to switch to the backup system when main power fails, and a timing circuit to optimize a voltage output of the system based on current battery voltage and a desired time period for the voltage output. The system can be set to operate only when the appliance is turned on, which optimizes the current and power required to provide backup power to the appliance for a maximum period of time. | 12-04-2008 |
20120150001 | Hyaluronic acid based glucose monitoring - The invention provides a method for using OCT human tissue scan data for tracking a scan structure in depth, follow change in structure position within an OCT scan from, for example, fasting glucose level to peak glucose level and back down again, and relate the structure position change to analyte concentration. In the preferred embodiment, the analyte of interest is glucose concentration and the target of interest is living human skin. A hyaluronic acid based mechanism is suggested for dermis thickness. Alternate embodiments of the method are presented, including curve fitting of topographic regions corresponding to trackable target features. | 06-14-2012 |
20130260785 | Locating System for Autistic Child and Others - Mentally challenged persons such as autistic children and Alzheimer's patients can become lost and they are hard to find because they have difficulty communicating or they are confused and disoriented. The present invention provides an apparatus, system and methods for locating lost persons (or animals or packages) whether they are indoors or outdoors. The apparatus comprises a cellular telephone unit which can be activated by a RF signal and which a child or patient can wear. The wearable unit can be activated by a caregiver's smart phone having a locating application installed therein. The locating application enables the caregiver to locate the lost person using radio direction finder triangulation when the lost person is within a few hundred feet of the caregiver. When the lost person is further away, the locating application employs cell phone tower triangulation or the wearable unit GPS/Assisted GPS application to determine an approximate location of the lost person. As the caregiver moves close enough to the approximate location, the radio direction finder triangulation is used to calculate a more exact location to find the lost person. | 10-03-2013 |
Patent application number | Description | Published |
20090149471 | Monocyclic Heterocyclic Compounds - This invention relates to compounds of the general formula: | 06-11-2009 |
20090156596 | Unsaturated Heterocyclic Derivatives - This invention relates to compounds of the general formula: | 06-18-2009 |
20090176781 | Acetylenic Heteroaryl Compounds - This invention relates to compounds of the general formula: | 07-09-2009 |
20110294806 | AZAINDOLE DERIVATIVES AS KINASE INHIBITORS - This invention relates to compounds of the general formula (I) in which the variable groups are as defined herein, and to their preparation and use. | 12-01-2011 |
20120135986 | Bicyclic Heteroaryl Compounds - This invention relates to compounds of the general formula: | 05-31-2012 |
20120178716 | Unsaturated Heterocyclic Derivatives - This invention relates to compounds of the general formula: | 07-12-2012 |
20120202776 | PHOSPHORUS DERIVATIVES AS KINASE INHIBITORS - The invention features compounds of the general formula (I) in which the variable groups are as defined herein, and to their preparation and use. | 08-09-2012 |
20120316135 | Compounds for Inhibiting Cell Proliferation in EGFR-Driven Cancers - The invention features compounds, pharmaceutical compositions and methods for treating patients who have an EGFR-driven cancer of formula I: | 12-13-2012 |
20120316137 | Methods and Compositions for Treating Cancer - The invention features methods, kits, and pharmaceutical compositions for treating cancer using 3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-(4-((4-methylpiperazin-1-yl)-methyl)-3-(trifluoromethyl)phenyl)benzamide. | 12-13-2012 |
20130005738 | Monocyclic Heteroaryl Compounds - This invention relates to compounds of the general formula: | 01-03-2013 |
20130018046 | Acetylenic Heteroaryl Compounds - This invention relates to compounds of the general formula: | 01-17-2013 |
20130178622 | Methods and Compositions for Treating Cancer - The invention features methods, kits, and pharmaceutical compositions for treating cancer using 3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-(4-((4-methylpiperazin-1-yl)-methyl)-3-(trifluoromethyl)phenyl)benzamide. | 07-11-2013 |
20130196979 | Bicyclic Heteroaryl Compounds - This invention relates to compounds of the general formula: | 08-01-2013 |
20130225527 | Phosphorus Derivatives as Kinase Inhibitors - The invention features compounds of the general formula: | 08-29-2013 |
20130225528 | Phosphorus Derivatives as Kinase Inhibitors - The invention features compounds of the general formula: | 08-29-2013 |
20130231337 | Bicyclic Heteroaryl Compounds - This invention relates to compounds of the general formula: | 09-05-2013 |
20140024620 | Methods for Inhibiting Cell Proliferation in EGFR-Driven Cancers - The invention features a method for treating patients who have an EGFR-driven cancer, which is, or has become, refractory to a tyrosine kinase inhibitor, such as eriotinib and gefitinib, by administering a compound of formula (I) to the patient. The invention also features treating EGFR-driven cancers having an EGFR mutation identified herein. | 01-23-2014 |
20140045826 | METHODS AND COMPOSITIONS FOR TREATING NEURODEGENERATIVE DISEASES - The invention discloses methods and compositions for treating or preventing neurodegenerative disease by administering a compound of Formula I: or a pharmaceutically acceptable salt, solvate or hydrate thereof, wherein the variables are defined as herein. | 02-13-2014 |
20140066406 | Phosphorus Derivatives as Kinase Inhibitors - The invention features compounds of the general formula: | 03-06-2014 |
20140066434 | Methods and Compositions for Treating Parkinson's Disease - The invention discloses methods and compositions for treating or preventing Parkinson's disease by administering a compound of Formula (I): or a pharmaceutically acceptable salt, solvate or hydrate thereof, wherein the variables are defined as herein. | 03-06-2014 |
20140288082 | Bicyclic Heteroaryl Compounds - This invention relates to compounds of the general formula: | 09-25-2014 |
20150105377 | Methods and Compositions for RAF Kinase Mediated Diseases - The invention discloses methods and compositions for treating or preventing RAF kinase mediated diseases or conditions by administering a compound of Formula 1: or a pharmaceutically acceptable salt, solvate or hydrate thereof, wherein the variables are defined as herein. | 04-16-2015 |
20150225436 | PHOSPHOROUS DERIVATIVES AS KINASE INHIBITORS - The invention features compounds of the general formula: | 08-13-2015 |